Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2025-05-21 Regulatory Filings
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Investor Presentation
Regulatory Filings
2025-05-21 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated May 21, 2025, announcing the financial results for the fourth quarter and full fiscal year ended March 31, 2025. It includes detailed financial performance data such as revenue, EBITDA, PAT, EPS, segmental revenue, and business highlights. The document also mentions an earnings conference call scheduled for the same day. The content is typical of an Earnings Release, which provides initial key highlights of quarterly or annual financial results. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. It is not a Management Discussion & Analysis (MDA) as it does not provide extensive management commentary beyond the press release summary. The document is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive financial data and analysis, not just an announcement or certification. Therefore, the most appropriate classification is Earnings Release (ER). Q4 2025
2025-05-21 English
Outcome of Board Meeting
Regulatory Filings
2025-05-21 English
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification to stock exchanges about the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, the increase in paid-up share capital, and compliance with SEBI regulations. The document is an announcement of a share allotment event, specifically related to employee stock options, and includes regulatory references and detailed share issuance data. It is not a financial report, earnings release, or management discussion, but rather a capital change announcement. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is under 5,000 characters and contains detailed information about the share allotment, not just a report publication or regulatory filing. Confidence is high due to clear regulatory references and detailed share issuance data.
2025-05-21 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015. It informs the stock exchanges about a tax assessment order received by the company from the Income Tax Authority. The document includes details of the order, the nature of the tax demand, and the company's position regarding the order. It is a regulatory announcement informing the market and regulators about a material event affecting the company, but it does not contain financial statements, detailed financial analysis, or a full report. The document length is 3026 characters, which is relatively short and consistent with a regulatory filing or announcement. There is no indication that this is a full financial report, audit report, or earnings release. It is not a report publication announcement since it contains substantive disclosure about the event itself. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-05-15 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended on March 31, 2025' and is issued pursuant to SEBI regulations related to the utilization of proceeds raised through a Qualified Institutions Placement (QIP). It includes detailed information on the use of funds, certifications by chartered accountants and CFO, and comments from the monitoring agency and the board of directors. The document is 15,000 characters long, indicating it is a full report rather than a brief announcement. The content focuses on monitoring the use of capital raised, which aligns with a report on capital/financing activities rather than a general financial report or earnings release. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2025-05-14 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.